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Abstract The inositol/choline-responsive el ment (ICRE) is an 
11 bp cis-activating sequence motif with central importance for 
the regulated expression of phospholipid biosynthetic genes in the 
yeast Saccharomyces cerevisiae. The ICRE containing the CA- 
NNTG core binding sequence (E-box) of basic helix-loop-helix 
(bHLH) regulatory proteins is recognized by the heteromeric 
bHLH transcription factor Ino2p/Ino4p. In this study, we define 
the Ino2p/Ino4p consensus binding sequence (5'-WYTTCAYR- 
TGS-3') based on the characterization of all possible single nucle- 
otide substitutions. Interestingly, this analysis also identified a 
single functional deviation (CACATTC) from the CANNTG core 
recognition element of bHLH proteins. The DNA binding speci- 
ficities of different yeast bHLH proteins may now be explained 
by distinct nucleotide preferences especially at two positions im- 
mediately preceding the CANNTG core motif. 
Key words. bHLH transcription factor; Phospholipid 
biosynthesis; Saturation mutagenesis; UAS element; 
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I. Introduction 
In the yeast Saccharomyces cerevisiae, many structural genes 
of phospholipid biosynthesis are coordinately regulated by the 
availability of the precursor molecules inositol and choline in 
the growth medium (reviewed in ref. [1]). Our studies on the 
transcriptional control of fatty acid synthase genes FAS1 and 
FAS2 led to the identification of a UAS element (upstream 
activation site) apparently involved in this general regulatory 
mechanism [2]. The respective UAS sequence was designated 
as inositol/choline-responsive element (ICRE) since gene acti- 
vation mediated by this motif turned out to be synergistically 
repressed by the two phospholipid precursors, inositol and 
choline [2]. The ICRE functions as a binding site for the tran- 
scription factor Fbfl which is composed of the two basic helix- 
loop-helix DNA-binding proteins, Ino2p and Ino4p [3,4]. After 
the identification of a common sequence motif, CANNTG, in 
the core of almost all known bHLH binding sites (E-box), it 
remained to be shown how different bHLH proteins distinguish 
between their individual targets. For the two yeast bHLH pro- 
teins Pho4p and Cpflp both binding to the same central 
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CACGTG element, nucleotides flanking this core motif were 
shown to be essential for their recognition specificity [5]. PH04 
encodes a transcriptional activator of genes involved in phos- 
phate supply, while CPF1 functions as a centromere DNA 
binding factor and is, in addition, required for methionine bio- 
synthesis. However, not only the peripheral positions but also 
the central part of the CANNTG element contributes todiffer- 
ential bHLH protein/DNA-interactions, as it was shown for the 
Myc/Max (binding to CACGTG; [6]) and MyoD proteins (pre- 
ferred binding to CAGCTG; [7]). 
From naturally occurring ICRE-like motifs as identified up- 
stream of various phospholipid biosynthetic genes, we derived 
the preliminary consensus sequence, 5'-TYTTCACATGY-3'. 
Other authors have suggested distinct variants of this ICRE to 
function as UAS elements. For instance, the octamer motif 
TTCAYATG was described as a UAS element in the phosphat- 
idylserine synthase gene (PSS1/CH01) promoter [8]. Actually, 
this motif is entirely contained within the above ICRE se- 
quence. Similarly, several copies of the nonamer element, 
ATTTCACAT, were proposed to function as regulatory sites 
upstream of the inositol-l-phosphate synthase gene IN01 [9]. 
In order to characterize the minimal structural requirements of 
a functional ICRE with respect o its length and nucleotide 
sequence, we subjected this element to a saturation mutagene- 
sis. As will be reported in this study, the data thereby obtained 
define, by functional criteria, an ICRE consensus sequence and 
quantify the relevance of distinct sequence variants. 
2. Materials and methods 
2.1. Yeast strains and media 
The Saccharomyces cerevisiae wild-type strain JS91.15-23 (MATc~ 
ura3 leu2 his3 trpl canl MAL3 SUC3) and the isogenic Aino2:.'LEU2 
mutant SS92.3-1 were used as recipients for transformation with re- 
porter plasmids. Synthetic complete media (SCD) suitable for the selec- 
tion of yeast transformants have been described [3]. Growth oftransfor- 
mants of the ino2 mutant was supported by the addition of a non- 
repressing amount of inositol+choline (final concentration 5/~M each). 
2.2. Construction of lCRE sequence var~mts 
ICRE sequence variants were generated by the insertion of double- 
stranded synthetic DNA fragments derived from the reference s quence 
5'-tcgagaaTTTTCACATGCagatct-Y (capital letters) into the XhoI re- 
striction site of reporter plasmid pJS205 (AUAS-CYCI-lacZ URA3 2 
/lm; [2]). Chemically synthesized oligonucleotides (MWG Biotech; 
Ebersberg, Germany) were mutated by using, at successively shifted 
dinucleotide positions, the four different nucleotide precursors with 
equal probability. The complementary strand was synthesized corre- 
spondingly. Annealing of both oligonucleotides created cohesive ends 
suitable for insertion into an XhoI site. The constructs were amplified 
in E. coli and characterized byDNA sequencing. A few variants not 
obtained by this method were synthesized, specifically. 
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2.3. Miscellaneous procedures 
Procedures of recombinant DNA, yeast ransformation, preparation 
of protein extracts and fl-galactosidase assay have been described previ- 
ously [3]. 
3. Results and discussion 
3.1. Importance of individual nucleotides for ICRE activity and 
specificity 
In order to distinguish between functional and non-func- 
tional ICRE variants, a saturation mutagenesis of the highly 
efficient, naturally occurring ICRE sequence 5'-TTTTCA- 
CATGC-Y was performed. The experimental strategy was 
based on the analysis of reporter gene activation upon insertion 
of the mutated synthetic DNA fragments into a AUAS-CYC1- 
lacZ promoter test plasmid [10]. This reporter construct allows 
by itself only basal gene expression and may be activated about 
40-fold by insertion of the functional ICREs present in the 
FAS1, FAS2 or INO1 promoters [2]. The sequence variants 
analysed in this study exhibited single nucleotide substitutions 
at positions N] -N ,  of the above sequence. The activation fac- 
tors observed with 44 different sequence variants in a S. cerevis- 
iae wild type strain are listed in Fig. 1. Quite generally, stimu- 
lation of basal gene expression was, with all ICRE variants 
tested, independent of their orientation (not shown). The syner- 
gistic effect of more than one ICRE in the same promoter has 
already been reported previously [2]. In order to rule out an 
unspecific gene activation by factors other than Ino2p/Ino4p 
which may bind to some of the sequences artificially created by 
the mutagenesis procedure, all insertion constructs howing at 
least 5-fold activation rates in the wild type were also trans- 
formed into an ino2 null mutant. In this mutant, ICRE-depend- 
ent gene activation is specifically abolished [4]. It was found 
that in all cases functional ICRE variants were indeed inactive 
in the ino2 mutant. In contrast, gene activation caused by a 
different UAS element (UASRpG=Raplp binding site; [11,12]) 
remained unaffected by the ino2 mutation (data not shown). In 
accordance with these results, the reporter constructs proved 
to be repressible by inositol+choline (not shown). Both kinds 
of control experiments confirmed for all ICRE variants tested 
the specificity of their regulation by the two phospholipid pre- 
cursors and the dependence of this regulation on a functional 
IN02 gene. 
Table 1 
Influence of selected ouble substitutions on ICRE-dependent gene 
activation 
(a) Substitutions at positions N 7 N 8 (TTTTCAYRTGC): 
Sequence Activation factor 
TTTTCACATGC 40 
TTTTCACGTGC 20 
TTTTCATATGC 24 
TTTTCATGTGC 35 
(b) Substitutions at positions Nj0 NH (TTTTCACATTN): 
Sequence Activation factor 
TTTTCACATTG 1 
TTTTCACATTA 1 
TTTTCACATTT 1 
TTTTCACATTC 17 
TTTTCACATGC 40 
TTTTCACATGG 40 
Activation factors were calculated as described in the legend of Fig. 1. 
position 
G 
A 
T 
C 
reference sequence 
consensus sequence 
optimal sequence 
N I N 2 N 3 N 4 N 5 
18 5 I 5 I 
647  153 1 
40 40 40 40 1 
17 44 1 9 40 
Ns N 7 NeNo I~c N11 
1 3 20 6 40 40 
40 1 40 8 1 13 
5 24 1 !40 17 20 
4 40 2 2 I 4O 
Fig. 1. Activation factors determined for reporter constructs containing 
ICRE sequence variants. Plasmids carrying single nucleotide substitu- 
tions within the ICRE reference sequence upstream of a CYCI-lacZ 
reporter gene were transformed into S. cerevisiae wild-type strain 
JS91.15-23 [4]. Transformants were subsequently assayed for specific 
fl-galactosidase activities. The activation factors were calculated with 
respect o the enzyme activity determined in pJS205 transformants 
(AUAS-CYCI-lacZ fusion construct). The ICRE consensus sequence 
was derived from sequence variants leading to a more than 20-fold gene 
activation. R: G or A; Y: C or T; W: A or T; S: G or C. 
Obviously, position N~ is not of critical importance but 
merely distinguishes between ICREs of high and intermediate 
strength; at N2, however, a pyrimidine residue is clearly pre- 
ferred to a purine. Similarly, functional ICREs should contain 
T residues at both positions, N3 and N4. Within the subsequent 
CANNTG core element (pos. N5 N~0), only the sequence 
CAYRTG mediates trong gene activation (Table l a lists the 
activation factors obtained for the 4 possible CAYRTG ele- 
ments). Any deviation from this consensus leads to a signifi- 
cantly reduced efficiency. Thus, the core sequence CACGTG 
present in the Pho4p and Cpflp binding sites should also allow 
recognition and effective activation by the Ino2p/Ino4p com- 
plex. According to the CANNTG rule of bHLH binding sites, 
no T nucleotide should be expected to be tolerated at position 
Nl0. Nevertheless, it may be effectively used at this site provided 
that it is followed by C at NH (Table lb). Otherwise, position 
N~I resembles N~ in being obviously not very critical, either. A 
similar deviation from the CANNTG rule has been observed 
for one of the Pho4p binding sites in the upstream region of the 
acid phosphatase gene PH05 [13]. While the bHLH protein 
Pho4p binds efficiently to a CACGTG core element (UASp2)  
of the PH05 promoter, the sequence CACGTT (UASp0 is 
recognized with only moderate affinity. Using a binding site 
selection technique, interaction of the c-Myc/Max heterodimer 
complex with non-canonical sites such as CACGCG, 
CACGAG and CACGTT could also be demonstrated [14]. In 
summary, the data of Fig. 1 allow the definition of two different 
ICRE consensus equences, WYTTCAYRTGS and WYTTC- 
ACATGS, exhibiting intermediate (at least 20-fold) and maxi- 
mal (at least 40-fold) transcriptional ctivation rates, respec- 
tively. 
The results of the ICRE saturation mutagenesis clearly allow 
to discriminate between binding sites of the yeast bHLH pro- 
teins Pho4p and Ino2p/Ino4p. Binding of Pho4p to a CACGTG 
motif was shown to be strictly inhibited by a T residue 5' to this 
core element (corresponding to position N4 in our analysis; [5]). 
In contrast, binding of Cpflp or Ino2p/Ino4p is definitely fa- 
voured by this arrangement. Thus, no interference between 
Pho4p and either Cpflp or Ino2p/Ino4p is expected to occur, 
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Table 2 
Compilation of Saccharomyces cerevisiae genes containing ICRE sequences in their upstream regions 
Phospholipld biosynthesis: Other functions: 
Gene Function Sequence Gene Function Sequence 
FAS1 Fatty acid synthase, ,8 subunit 
FAS1 Fatty acid synthase, ,8 subunit 
FAS2 Fatty acid synthase, ¢E subunit 
ACCI AcetyI-CoA carboxylase 
FAA 1 AcyI-CoA synthetase 
FAA 1 Ac'yt-CoA synthetase 
ACB1 AcyI-COA binding protein 
ITR1 inositol perrnease 
ITR 1 Inositol permease 
CTRI Choline permease 
IN01 Inositol-t -phosphate synthase 
IN01 Inositol-l-phosphate aynthase 
IN01 Inositol-t -phosphate eynthase 
IN01 Inositol-l-phosphata synthase 
CH01 Phosphatidylserine eynthase 
CPT1 Diacylglycerol cholinephosphotransferase 
PSD I Phosphatidylserice decerboxylase 
PSD I Phosphatidylserine decarboxylase 
CKJl Choline kinase 
PEM1 Phosphatidylet hanolamlne N-methyltrensferase 
PEM1 Phosphatidylet henolamine N-methyltransferase 
PEMI Phosphatidylethanolemine N-methyitransferase 
PEM2 Phosphatidylethanolamine N-methyltransferase 
PEM2 Phosphatidylat hanolamine N-mathyltransferase 
PEM2 Phosphatidylet hanolamine N-mathyltransfersse 
PISI Phosphatidylinositol aynthase 
SLC 1 Long.chain acyI-coA transferase 
SLC1 Long-chain acyI-CoA transferase 
GUTI Glycerol kinasa 
URA8 CYP synthatase 
IN02 Positive regulator of phospholipid biosynthesis 
IN04 Positive regulator of phospholipld biosynthesis 
OPI1 Negative regulator of phospholipid biosynthesis 
t i t t CACATGC ARG4 Argininosuccinate lyase TTTTCACATGT 
Ac'rrCACATGC MET2 Homoserine O.trsnsacetylese TTTTCACGTGA 
= t i t CACATGC MET8 Unknown ATTTCACGTGT 
TCTTCACATGG MET14 ATP:edenylylsulfate-3'-phosphotransferase ATTTCACGTGA 
TATTCACATGG MET16 3'-Phosphoadenytylsuffate reductase ATTrCACGTGA 
TCTTCATATTC SAM2 S-adenosylmethionine synthetase TCTTCACATGT 
ATTTCACATGT SAM2 S-adenosylmathionine synthetase TCTTCATATGC 
TCTI'CACATGC MSW1 Mitochondrial tryptophanyl-tRNA synthetase TTTTCACGTGA 
t t I i CACATGC ADE12 Adenylosuccinate synthetase TTTTCATATGT 
i J i I CACATGC CDC8 Thymidylate kinase ACTTCATATGC 
! i i i CACATGC CDC8 Thymidylate kinase TTTTCATATGA 
AATTCACATGG CYC7 Iso-2-cytochrome c GTTTCACATGC 
ATTTCACATTC COX4 Cytochrome oxidase, subunit IV TTTrCACATGA 
TCATCATATGC SODI Cu ,Zn-soperoxiddismutase ATTTCACATGG 
CTTTCACATGG MAL61 Maltose permease TTTTCATGTGT 
I 11 I CACATGC FPP1 Farnesylpyrophosphate synthetase TTTTCACATGT 
ATATCACATGC MFal ,,-factor precursor I I I I CACATGG 
TTTCCACATGC STE2 a-factor receptor TCTTCATATGT 
TATTCACATGG STE4 ,8-subunit of receptor-coupled G-protein ccTrCACATGA 
AATTCACATGT CCL1 Negative regulator of pheromone response TCTTCATGTGT 
I i t l  CATATGC SWI5 Regulatory gene of mating type switch I I I I CACATGC 
TCTTCACATGA KARl Nuclear fusion TCTfCACATTC 
TTTCCACATGC KSS1 Protein kinase TTITCACA'n'c 
TCTTCATATGC YCK1 Casein kinase I TITrCATGTGG 
TCTTCATATGT NUF1 Component of nucleoskeleton ATTrCATATGT 
ACTTCATATGC SAC6 F3mbrin (Actin binding protein) TTTTCACATGA 
CCTTCATATGA MSB1 Morphogenesia ATTrCATGTGC 
GCTTCACATTC RAD9 Cell cycle arrest protein ATTrCATATGT 
i i t J CACATGG RAD23 Excision repair protein ACTTCATATGT 
TCTTCACATTC RAD52 Recombination protein TTTTCATATGT 
AATTCACATGT GCR2 Glycolysis regulator Tc'n'CACATTC 
TATTCACATGT MCM3 Minichromosome maimenence TTTTCATGTGC 
TCTTCATATGC CAP I Capping protein, =-eubunit TTTTCACATTC 
YEF3 Elongation factor 3 TTTTCACGTGC 
PMA2 Transport ATPase ACTTCATATGT 
AFG2 Putative ATPase Tc'n'CATATGT 
PEP12 Sorting of vacuolar proteinasee "ITTTCATGTGA 
PTP2 Tyrosine phosphatase c'n-ICACATGC 
Bold letters indicate UAS elements with an at least 40-fold activation capacity. Open reading frames of unknown function 
identified by systematic sequencing of the S. cerevisiae genome were not considered for this compilation. 
in vivo. On the other hand, discrimination between Cpflp and 
Ino2p/Ino4p binding is less clear although some specificity may 
be accomplished by nucleotides NrN 3. This is evident from the 
Cpflp consensus equence RTCACGTG (centromere DNA 
element, CDEI; [15,16]) being unlikely to interact efficiently 
with Ino2p/Ino4p due to the purine residue corresponding to
position N 3 of the ICRE. However, analysis of the in vitro 
DNA-binding capacity of Cpflp and of the in vivo mitotic 
stability of mutant CDEI sequences revealed for the CEN6 
CDEI variant TCTTCACGTGC only a moderate loss of func- 
tion (wild-type CEN6 CDEI: TCATCACGTGC; [17]). Since 
the mutant CDEI sequence is expected to mediate about 20- 
fold INO2llNO4-dependent gene activation (cf. Table la), the 
DNA binding specificities of Cpflp and Ino2p/Ino4p may in- 
deed overlap to a certain extent. Thus, an ICRE with A at 
position N 3 should be recognized by both, Cpflp and Ino2p/ 
Ino4p, while another element with G at this place would ex- 
clude Ino2p/Ino4p binding (cf. Fig. 1). It is therefore concluded 
that some ICRE sequence variants with ambivalent bHLH 
protein binding characteristics may acquire their functional 
specificity by additional criteria. Interactions with specific reg- 
ulatory proteins or other functional differences between Cpflp 
and Ino2p/Ino4p may guarantee their specificities despite some 
ambiguity of binding site recognition. In support of this view, 
Cpflp obviously lacks a transcription activation domain [18], 
while Ino2p is a genuine activator even in the absence of Ino4p 
[4]. 
3.2. Yeast structural genes possibly controlled by an ICRE 
In order to identify additional structural genes possibly being 
transcriptionally controlled by the Ino2p/Ino4p activator, we 
performed a Saccharomyces cerevisiae data base search using 
the ICRE consensus sequence defined in Fig. 1. Several of the 
numerous ICRE-like elements thus identified are listed in Table 
2. This Table includes only those elements which are located 
in the 5'-flanking promoter regions of the respective genes and 
which mediate transcriptional ctivation by a factor of >7 (cf. 
Fig. 1). In addition to a large number of ICRE-like sequences 
mapping to upstream regions, several motifs perfectly matching 
the ICRE consensus were also found within coding regions (not 
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shown). The biological significance of ICREs within reading 
frames may be questioned, since UAS elements usually do not 
function from a downstream position [19]. Remarkably, the 
promoters of all currently known genes of phospholipid biosyn- 
thesis contain at least one copy of the ICRE. However, for only 
few of them, such as FAS1 and FAS2 [2], IN01 [9], PEM1, 
PEM2 [20], PSS1/CH01 [8,21], ITR1 [22] and ACC1/FAS3 
[23,24], these elements were definitely shown to be important 
for the efficient transcriptional ctivation of the respective 
genes. In a previous tudy, we postulated the existence of two 
ICREs in the 1NO1 upstream region [2]. According to the 
results of this work, two additional motifs (one of which is a 
non-canonical bHLH binding site) may also contribute to the 
marked inositol/choline r gulation of IN01 (cf. Table 2). 
Interestingly, the promoter of the glycerol kinase gene GUT1 
also contains a perfect ICRE. Since glycerol-3-phosphate func- 
tions as a recipient of long-chain fatty acids from the corre- 
sponding acyl-CoA residues, GUT1 may be under dual control: 
the transcriptional ctivator Adr lp  has been shown to be re- 
sponsible for the carbon source control of the gene [25] while 
Ino2p/Ino4p could mediate its regulation by phospholipid pre- 
cursors. Similarly, the ICRE upstream of the CTP synthetase 
gene URA8 indicates an Ino2p/Ino4p-dependent control of 
CTP biosynthesis which provides the coenzyme necessary for 
the production of activated metabolites such as CDP-choline 
or CDP-diacylglycerol. It should be emphasized that the pro- 
moters of several regulatory genes of phospholipid biosynthe- 
sis, such as IN02, IN04 and OPI1, also contain weak ICRE 
sequences. This may be important for the autoregulatory con- 
trol of these genes ([3]; unpublished). 
Besides phospholipid biosynthetic genes, Table 2 also lists a 
considerable number of additional genes as candidates for an 
ICRE-dependent control without any common functional 
characteristics being evident among them. Interestingly, several 
genes of methionine biosynthesis contain an ICRE in their 
respective upstream regions. Although the T nucleotide at posi- 
tion N 3 for the ICRE-like elements of MET2, MET8, MET14, 
MET16 and SAM2 argues for an Ino2p/Ino4p rather than a 
Cpflp binding site, no methionine requirement was observed 
with ino2 or ino4 null mutants. Similarly, overexpression of
both IN02 and IN04 by appropriate increases of their gene 
dosages could not complement the methionine auxotrophy of 
a cpfl null mutant. Although the ICREs in the various MET 
promoters may be targets of both Ino2p/Ino4p and Cpflp (see 
above), the Ino2p/Ino4p heterodimer may fail to act synergisti- 
cally with additionally necessary components of the methionine 
activation system such as the genuine transcriptional ctivator 
Met4p [18]. Thus, the possible significance of INO2/IN04 for 
the expression of a structural gene with an ICRE in its upstream 
region obviously requires individual testing. The impaired 
growth characteristics of ino2/ino4 null mutants even on inosi- 
tol/choline-supplemented rich media argue for an additional 
function of the Ino2p/Ino4p activator beyond its role in phos- 
pholipid biosynthesis. The data compiled in Table 2 may pro- 
vide clues to the possible targets of these additional functions 
of the Ino2p/Ino4p transcription factor. 
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